Fmoc SPPS strategy:
SPPS was carried out on a Syro II MultiSyntech Automated Peptide synthesizer (Tip synthesis module, 96 positions reaction block), using standard 9-fluorenylmethoxycarbonyl (Fmoc) based solid phase peptide synthesis protocols in 2 µmol scales. All amino acids were used in excess and depending on the sequence, special dipeptides were used in specific positions, as previously reported 1 . All the procedures for the library synthesis were carried out in parallel following reported procedure 2 .
To the protected ubiquitin (1) (positioned in the 96-reaction block) on trityl resin, 200 µL of a mixture in NMP of PyBOP (5.0 eq), diBoc-rhodamine (5.0 eq) or 5-carboxy-tetramethylrhodamine (TMR, in library I), DIPEA (10.0 eq) was added in parallel. After overnight coupling, the resins were washed with 2 x NMP and then 4 x DCM. The synthesis of diBoc-rhodamine was previously reported by our group 3 .
Fully protected Ub (2) was cleaved from the resin by adding a solution of 200 µL of 20 % HFIP in DCM. After 30 min, the flow-through containing protected Ub with a free C-terminus was collected in a 96 deep well plate. The procedure was repeated twice. The flow-through was dried under N2 flow and then freeze-dried using a mixture of CH3CN/H2O (1:1) overnight.
The crude product (3) obtained after freeze-drying was dissolved in 100 µL DMF. To the mixture we added 100 µL of a freshly made solution of PyBOP (5.0 eq), propargylamine (5.0 eq) and DIPEA (10.0 eq) and allowed to react overnight. Afterwards we added a mixture of CH3CN/H2O (1:1) to the reaction mix, prior to freeze-drying. 400 µL of freshly prepared cleaving mixture (TFA/TiPS/Phenol/H2O; 92.5/2.5/2.5/2.5; v/v/v/v) was added to the crude material (4) present in the 96 deep well plate. After 2.5 h we added a cold mixture of Et2O/Pentane (3/1), leading to the precipitation of the synthetic ubiquitin. After 2 rounds of washes with cold Et2O, the precipitate was freeze-dried with CH3CN/H2O (1:1) overnight. The crude material (5) was dissolved in 500 µL DMSO and purified with the preparative HPLC. The pure fractions were analysed by LC-MS and combined and freeze-dried. All purified synthetic mutants were dissolved in DMSO to a final concentration of 2.0 mM. They were further diluted in MQ water until a final concentration of 20 µM.
Cell culture HAP1 cells and USP7KO HAP1 (obtained from Horizon Genomics HAP1_USP7_00485-02) were cultured in IMDM (Gibco) supplemented with with 10% FCS and 1% Pen/Strep (FCS, Greiner). Cells were cultured at 37°C and 5 % CO2.
Labelling experiments
Cell were lysed in 50 mM Tris, 150 mM NaCl, 0.5 % Triton X-100, pH=7.5. Final concentration of 2.0 mM DTT was used in the labeling experiments. HAP1 lysate (10 µL) was incubated for 30 min with the different synthetic mutants at a final concentration of 1.0 µM. Samples were separated by gel electrophoresis (4-12 % SDS-PAGE, precast gel from Invitrogen, in MOPS buffer, if not stated otherwise). In order to analyse the levels of the labelled DUBs, we used a Typhoon FLA 9500 (GE Healthcare LifeSciences using filters with λEx =473 and λEm =532) for fluorescence scanning.
Western-blotting
Proteins were transferred to a nitrocellulose membrane from Trans-Blot Turbo Mini Nitrocellulose Transfer Packs from Bio-Rad using a 7 min program for different molecular weight proteins (Trans-Blot Turbo Transfer System from Bio-Rad) The membranes were blocked in 5 % BSA in Tris buffer pH=7.5 (50 mM Tris, 150 mM NaCl). Subsequently they were incubated with a primary antibody diluted in 1 % BSA in 0.1 % Tris buffer -Tween 20 (TBST) for 1 h, washed three times for 5 min in 0.1 % PBST, then incubated with the secondary antibody diluted in 1 % BSA in 0.1 % TBST for 30 min and washed three times 5 min in 0.1 % TBST. β-actin antibody (Sigma-Aldrich, Cat# A5441) was used as a loading control in a 1:10000 dilution and USP7 antibody (Abcam, ab4080) was used at a dilution of 1:1000. As secondary antibodies we used IRDye 680LT goat anti-mouse IgG (H+L) (926-68020, Li-COR) and IRDye 800LT goat anti-rabbit IgG (H+L) 926-32211, Li-COR). The signal was detected using direct imaging by the Odyssey Classic imager (Li-Cor).
Pull-down experiment 1x10 6 cells were seeded in each 10 cm dish, in total 3 dishes per conditions. After 48 h, the cells were lysed in Tris buffer pH=7.5 (50 mM Tris, 150 mM NaCl) 0.5 % Triton X-100. The lysates were incubated with Rh-M6-PA or no probe for 30 min at 30 o C, slowly shaking. The neutravidin beads (Thermo Fischer SCIENTIFIC) were washed twice with lysis buffer before addition. 50 µL of the 50 % aqueous slurry were added to the lysates and they were incubated at 4 o C for 2.5 h. The beads were collected after being centrifuged at 1000 rpm at 4 o C. The beads were washed multiple times in lysis buffer. 10 % of the final beads were boiled at 100 o C in loading buffer and then analyzed by gel electrophoresis, followed by western blotting. The experiments were performed in triplicate for each of the following conditions. 1) HAP1 WT lysate with no probe (Control) 2) HAP1 WT lysate labelled with the probe 3) USP7KO HAP1 labelled with the probe Mass spectrometry sample preparation.
Trypsin (V5111, Promega) digestions and peptide sample preparation were carried out according to the previously described protocols 4 .
Mass spectrometry LC-MS/MS analysis was performed on an EASY-nLC 1000 system (Proxeon, Odense, Denmark) connected to a Q-Exactive Orbitrap (Thermo Fisher Scientific, Germany) through a nano-electrospray ion source. The Q-Exactive was coupled to a 15 cm analytical column with an inner-diameter of 75 μm, in-house packed with 1.9 μm C18-AQ beads (Reprospher-DE, Pur, Dr. Maish, Ammerbuch-Entringen, Germany).
The chromatography gradient length was 60 minutes from 2% to 95% acetonitrile in 0.1% formic acid at a flow rate of 200 nL/minute. The mass spectrometer was operated in data-dependent acquisition (DDA) mode with a top-10 method. Full-scan MS spectra were acquired at a target value of 3 x 10 6 and a resolution of 70,000, and the Higher-Collisional Dissociation (HCD) tandem mass spectra (MS/MS) were recorded at a target value of 1 x 10 5 and with a resolution of 35000 with a normalized collision energy (NCE) of 25%. The maximum MS1 and MS2 injection times were 50 ms and 120 ms, respectively. The precursor ion masses of scanned ions were dynamically excluded (DE) from MS/MS analysis for 60 sec. Ions with charge 1, and greater than 6 were excluded from triggering MS2 analysis.
Mass spectrometry data analysis Proteomics data were analyzed using MaxQuant software (v1.5.3.30) according to, Tyanova et al 5 . using default settings with the following modifications: Label Free Quantification (LFQ) was employed with the Fast-LFQ algorithm disabled. We performed the search against an in silico digested UniProt reference proteome for Homo sapiens (18 th June 2018). The match-between-runs feature was enabled with a 0.7 min match time window and a 20 min alignment time window.
Output files from MaxQuant were further processed in the Perseus (v 1.5.5.3) computational platform 6 . Proteins identified as common contaminants, only identified by site and reverse peptide were filtered out, and then all the LFQ intensities were log2 transformed. Different biological repeats of the experiment were grouped and only protein groups identified in all three biological replicates in at least one group were included for further analysis. Missing values were imputed using Perseus software by normally distributed values with a 1.8 downshift (log2) and a randomized 0.3 width (log2) considering whole matrix values. T-tests comparing the different groups were performed with a permutation based FDR of 0.05. Spreadsheets from the statistical analysis output were further processed in Microsoft Excel from comprehensive visualization and data analysis. Volcano plots were generated with a permutation based FDR of 0.05 and S0=0.1.
Mass spectrometry data availability.
The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE 7 partner repository with the dataset identifier PXD012535.
Library screening:
The list of the mutants for each library and DUB activity-based probe assays are shown. The list of the special amino acids building blocks and their abbreviations used in these screening is as follows.
Pentafluoropheylalanine=5; Lys(Me3Cl)=9 (K-trimethyl); Gln(Dmcp)=!; Lys(ivDde)=$; Glu(biotinyl-PEG)=#; Lys(biotin)=Z (K-bio).
Chart 1 Building blocks of the special amino acids Fig. S1. DUB activity-based probe assay for Library I. Labelled DUBs were analysed using in-gel fluorescence scanning. Labelling of USP7KO HAP1 lysate with wild-type ubiquitin reagent was used as control. a) DUB activity-based probe assay for the active mutants from library I (Part I); b) A list of the main mutants (Library I, Part I) which have shown a decrease in labelling for USP14 and in the LMW region, still labelling USP7; c) DUB activity-based probe assay for mutants from library I (Part II). *= labelled USP7; LMW=Low Molecular Weight Fig. S2 . Representation of the superimposition of the structure of USP7 catalytic domain (blu, PDB ID: 1NBF) to the crystal structure of USP5 in complex with ubiquitin (light green, PDB ID: 3IHP). Not all the motif of USP5 are present in this figure, only the ones interacting with ubiquitin. Residues R54 and D58 show close interaction with a motif of USP5 (red circle) which is absent in the case of USP7. The figure was generated using USCF Chimera. . DUB activity-based probe assay analysed using in-gel fluorescence scanning. a) DUB activitybased probe assay for all the mutants from Library II and a few mutants from Library I; b) another round of labelling experiments for a few hits from library II. Labelling of USP7KO HAP1 lysate with wildtype ubiquitin reagent was used as control. *=labelled USP7 Rh-MQIFVKDYTGKTRTLEVEPSDTIENVKAKIQDKLGIPPDQQRLIFAGKQLEDGZTLSDYNIQKESTLHAVARLRG-PA  T7D,L8Y,I13R,E34L,R54K-bio,L69A,L71A,   LIIIM2  Rh-MQIFVKDYTGKTRTLEVEPSDTIENVKAKIQDKLGIPPDQQRLIFAGKQLEDGRTLSZYNIQKESTLHAVARLRG-PA  T7D,L8Y,I13R,E34L,D58K-bio,L69A,L71A   LIIIM3  Rh-MQIFVKDYTGKTRTLEVEPSDTIENVKAKIQDKLGIPPDQQRLIFAGKQLEDGRTLSYYNIQKESTLHAVARLRG-PA  T7D,L8Y,I13R,E34L,D58Y,L69A,L71A,   LIIIM4  Rh-MQIFVKDYTGKTRTLEVEPSDTIENVKAKIQDKLGIPPDNQRLIFAGKQLEDGZTLSDYNIQKESTLHAVARLRG-PA  T7D,L8Y,I13R,E34L,Q40N,  R54K-bio,L69A,L71A,   LIIIM5  Rh-MQIFVKDYTGKWRTLEVEPSDTIENVKAKIQDKLGIPPDQQRLIFAGKQLEDGZTLSDYNIQKESTLHAVARLRG-PA  T7D,L8Y,T12W,I13R,E34L,  R54K- Fig. S4 . DUB activity-based probe assay for Library III. Labelled DUBs were analysed using in-gel fluorescence scanning. Labelling of USP7KO HAP1 lysate with wild-type ubiquitin reagent (WT) was used as control. LIIM6 and LIIM7 were the best hits from Library II. *=labelled USP7 Fig. S5 . a) DUB activity-based probe assay for the best hits from Library III. Labelled DUBs were analysed using in-gel fluorescence scanning (8 % precast gel, in MES buffer). In this case the labelling experiments were performed with 3x less final concentration of the probes. From all the mutants, Rh-M6-PA (LIIIM6) demonstrated higher reactivity towards USP7, confirmed by western blotting. β-actin was used as loading control; b) mutations present in the best hits. *=labelled USP7 
Analytical data
For a few of the mutants the analytical data are reported: a) UV chromatogram (λ =190-600 nm); b) mass spectrum using LC-MS; c) mass spectrum of the main peak; d) deconvoluted mass of the spectra shown in c. 
